| Literature DB >> 36093363 |
Junyi Hu1, Thomas William Whyke1, Joaquin Lopez-Mugica2.
Abstract
Human papillomavirus (HPV) is one of the most common sexually transmitted infections worldwide. The HPV vaccination has been widely advocated around the world since the vaccine is beneficial in avoiding diseases, including some sexually transmitted diseases, brought on by HPV infections. For most Chinese, the HPV vaccine is still a relatively new concept, having only been made available to the general public in 2016. Despite the vaccine's increased prominence, there is still a lack of investigation about how the public is influencing the conversation about HPV vaccines and the public's perception of this vaccine. With the theoretical construct of the Health Belief Model, this study conducts both quantitative and qualitative content analysis to investigate the existing media narratives around HPV vaccines in China and the changes in public opinion by looking at users' contributions on Weibo, one of China's most popular social networking sites. It was found that different groups of Weibo users had contributed to diverse narratives surrounding HPV vaccination. Though the public awareness of HPV vaccination had been improved along with increasingly active communication practices and enhanced public health services, public knowledge about HPV remains inadequate. Therefore, to facilitate the popularisation of HPV related knowledge, more effort should be invested in tailoring and disseminating messages that communicate responsive and comprehensive HPV related information.Entities:
Keywords: China; Content Analysis; Health Belief Model; Human Papillomavirus Vaccines; Sexual Health; Social Media; Vaccination Awareness
Year: 2022 PMID: 36093363 PMCID: PMC9443650 DOI: 10.1007/s12119-022-10017-3
Source DB: PubMed Journal: Sex Cult ISSN: 1095-5143
Sampling
| Time period | Sampling time frame | Number of original posts identified by Python | Numbers of posts in the final sample | Number of posts included in subsample A | Number of posts included in subsample B |
|---|---|---|---|---|---|
| Before | 17/03/2020–23/03/2020 | 1305 | 1080 | 108 | 20 |
| 14/04/2020–20/04/2020 | 1544 | 1204 | 120 | 20 | |
| After | 21/04/2020–27/04/2020 | 3247 | 2410 | 241 | 20 |
| 19/05/2020–25/05/2020 | 2915 | 2223 | 222 | 20 | |
| Total | 9011 | 6917 | 691 | 80 |
Fig. 1An illustration of the analysis procedure
Fig. 2Word clouds of top 20 reposted Weibo posts of four weeks
Presentation of HBM components across different author groups
| Author Groups | HBM components | |||||
|---|---|---|---|---|---|---|
| perceived susceptibility | perceived severity | perceived benefits | perceived barriers | self-efficacy | cues to action | |
| Media organisations (N = 22) | 2 (9.1%) | 1 (4.5%) | 4 (18.2%) | 1 (4.5%) | 14 (63.6%) | 4 (18.2%) |
| Governmental accounts (N = 25) | 6 (24.0%) | 2 (8.0%) | 9 (36.0%) | 0 (0.0%) | 11 (44.0%) | 8 (32.0%) |
| Health organisations or professionals (N = 65) | 44 (67.7%) | 28 (43.1%) | 27 (41.5%) | 1 (1.5%) | 8 (12.3%) | 1 (1.5%) |
| Ordinary users (N = 579) | 40 (6.9%) | 25 (4.3%) | 37 (6.4%) | 84 (14.5%) | 97 (16.8%) | 172 (29.7%) |
| Total (N = 691) | 92 (13.3%) | 56 (8.1%) | 77 (11.1%) | 86 (12.4%) | 130 (18.8%) | 185 (26.8%) |
Presentation of HBM components in different time frames
| HBM components | Before the launch | After the launch | Chi-square | |
|---|---|---|---|---|
| Perceived susceptibility | 39 (5.6%) | 53 (7.7%) | 4.2 (1, | 0.040 |
| Perceived severity | 24 (3.5%) | 32 (4.6%) | 2.7 (1, | 0.102 |
| Perceived benefits | 32 (4.6%) | 45 (6.5%) | 15.7 (4, | 0.003 |
| Perceived barriers | 32 (4.6%) | 54 (7.8%) | 2.9 (5, | 0.714 |
| Self-efficacy | 30 (4.3%) | 100 (14.5%) | 10.1 (3, | 0.018 |
| Cues to action | 51 (7.4%) | 134 (19.4%) | 24.4 (2, n = 691) | < 0.001 |
Keywords of highest occurrence in top 20 retweeted Weibo posts
| Word cloud a | Freq | Word cloud b | Freq | Word cloud c | Freq | Word cloud d | Freq |
|---|---|---|---|---|---|---|---|
| Vaccine | 65 | Vaccine | 55 | Vaccine | 46 | Vaccine | 34 |
| Booking | 22 | Vaccination | 25 | Vaccination | 13 | Suggest | 15 |
| Cervical cancer | 15 | Booking | 14 | Cervical cancer | 10 | Vaccination | 12 |
| Virus | 11 | Cervical cancer | 9 | Launch | 9 | Two Sessions | 8 |
| Online | 9 | Virus | 8 | Virus | 7 | Proposal | 8 |
| Conduct | 8 | This time | 7 | Domestic | 6 | Female | 7 |
| Prevent | 7 | Prevent | 6 | Available | 6 | Include | 7 |
| This time | 6 | Conduct | 5 | Content | 5 | Country | 6 |
| Centre | 5 | Start | 4 | Price | 5 | Free | 6 |
| Regular | 4 | Notice | 4 | Knowledge | 5 | Planning | 5 |
Codebook
| Variable name | Definition | Operationalisation | |
|---|---|---|---|
| 1 | Author | The creator of the post | 1: Media organisations 2: Governmental accounts (government or governmental departments) 3: Health organisations or professionals 4: Ordinary users |
| 2 | Time period | The time of the post published on Weibo | 1: Before the release of domestic vaccine 2: After the release of domestic vaccine |
| 3 | Perceived susceptibility | The likelihood of being infected by HPV-related diseases | 0: No susceptibility mentioned 1: Susceptibility mentioned |
| 4 | Perceived severity | The severity of getting HPV-related diseases | 0: No severity mentioned 1: Severity mentioned |
| 5 | Perceived benefits | The benefits of injecting HPV vaccine | 0: No benefits mentioned 1: prevent cervical cancer 2: prevent STDs 3: prevent cancer in general 4: prevent diseases caused by HPV in general |
| 6 | Perceived barriers | Difficulty one may encounter in getting HPV vaccine | 0: No barriers mentioned 1: Difficulty in booking a vaccination slot 2: Side effects 3: Price too high 4: Fake vaccine 5: COVID-19 pandemic (travel restrictions and control policies) |
| 7 | Self-efficacy | The faith in one’s ability to get HPV vaccine | 0: no efficacy included 1: Ways to get the vaccine (by appointment/visit the hospitals) 2: Vaccine information (cost, suitable age for vaccination, producer, etc.) 3: both the ways to get vaccine and vaccine-related information are mentioned |
| 8 | Cues to action | The information or strategies that prompt one’s readiness to receive HPV vaccination | 0: no cues to action included 1: Statement or proposal from policy makers or government 2: Personal experience of getting vaccinated |